SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024159
Filing Date
2022-11-10
Accepted
2022-11-10 07:26:29
Documents
67
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vigl-20220930.htm   iXBRL 10-Q 3090846
2 EX-31.1 vigl-ex31_1.htm EX-31.1 23903
3 EX-31.2 vigl-ex31_2.htm EX-31.2 23867
4 EX-32.1 vigl-ex32_1.htm EX-32.1 14882
5 EX-32.2 vigl-ex32_2.htm EX-32.2 14864
  Complete submission text file 0000950170-22-024159.txt   9528085

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vigl-20220930_cal.xml EX-101.CAL 44952
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vigl-20220930_def.xml EX-101.DEF 302640
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vigl-20220930_pre.xml EX-101.PRE 423958
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vigl-20220930.xsd EX-101.SCH 67494
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vigl-20220930_lab.xml EX-101.LAB 512047
61 EXTRACTED XBRL INSTANCE DOCUMENT vigl-20220930_htm.xml XML 1468368
Mailing Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142
Business Address 1 BROADWAY, 7TH FLOOR, SUITE 07-300 CAMBRIDGE MA 02142 857-254-4445
Vigil Neuroscience, Inc. (Filer) CIK: 0001827087 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41200 | Film No.: 221374941
SIC: 2836 Biological Products, (No Diagnostic Substances)